Professor Alberto Bernabe -
The John Marshall Law School
Monday, July 8, 2013
Comment on dismissal of Fosamax case
A few days ago I posted that the court dismissed one of the many claims against pharmaceutical Merck for inadequate warnings related to its drug Fosamax on preemption grounds. See here. Today, Pharmalot has a comment on the case here.